[1] 戴朝明,靳松,张济周.大黄蛰虫丸联合TACE术对原发性肝癌患者(瘀血阻络型)VEGF、MMP-2、TGF-β1及免疫功能的影响[J].中国中药杂志,2021,46(3):722-729. Dai C M,Jin S,Zhang J Z.Effects of Dahuang Zhechong Pill combined with TACE on VEGF,MMP-2,TGF-β1 and immune function in patients with primary liver cancer of blood stasis obstructing collaterals type[J].China J Chin Mater Med,2021,46(3):722-729. [2] 李芮宁,黄超艺,洪畅,等.非甾体抗炎药对原发性肝癌抗PD-1疗效的影响[J].南方医科大学学报,2022,42(5):698-704. Li R N,Huang C Y,Hong C,et al.Effect of non-steroidal anti-inflammatory drugs on anti-PD-1 therapy for primary liver cancer[J].J South Med Univ,2022,42(5):698-704. [3] 刘戈.肝癌细胞与肝癌干细胞糖代谢的比较研究[D].重庆:重庆大学,2020. Liu G.Comparative study on glucose metabolism between liver cancer cells and liver cancer stem cells[D].Chongqing:Chongqing University,2020. [4] Mishra L,Banker T,Murray J,et al.Liver stem cells and hepatocellular carcinoma[J].Hepatology,2009,49(1):318-329. [5] Tang C,Zhang H,Deng W S,et al.Role of POU1F1 promoting the properties of stemness of gastric carcinoma through ENO1-mediated glycolysis reprogramming[J].Kaohsiung J Med Sci,2023,39(9):904-915. [6] Yang Y,He J,Zhang B,et al.SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer[J].Cell Death Dis,2021,12(12):1108. [7] 陈圆圆.HBx诱导BNIP3L依赖性线粒体自噬介导糖酵解代谢重编程调控肝癌细胞干性表型的机制研究[D].厦门:厦门大学,2019. Chen Y Y.Mechanism of HBx-induced BNIP3L-dependent mitophagy-mediated glycolytic metabolic reprogramming in regulating the stemness phenotype of hepatocellular carcinoma cells[D].Xiamen:Xiamen University,2019. [8] Chen B F,Chan W Y.The de novo DNA methyltransferase DNMT3A in development and cancer[J].Epigenetics,2014,9(5):669-677. [9] 倪唯益,夏卫,顾峻,等.SALL3基因启动子区域异常高甲基化肝癌患者预后不良[J].实用预防医学,2018,25(7):780-783. Ni W Y,Xia W,Gu J,et al.Abnormal hypermethylation of the SALL3 gene promoter region is associated with poor prognosis in patients with hepatocellular carcinoma[J].Pract Prev Med,2018,25(7):780-783. [10] Rona G B,Eleutherio E C A,Pinheiro A S.PWWP domains and their modes of sensing DNA and histone methylated lysines[J].Biophys Rev,2016,8(1):63-74. [11] Zhang J Z,Wang Y Q,Liu Q J,et al.MAGEA1 inhibits the expression of BORIS via increased promoter methylation[J].J Cell Sci,2019,132(1):jcs218628. [12] Dou X Y,Boyd D J,Bhattacharjee M,et al.The strand-biased mitochondrial DNA methylome and its regulation by DNMT3A[J].Genome Res,2019,29(10):1622-1634. [13] Zhu X,Xuan Z,Chen J,et al.How DNA methylation affects the Warburg effect[J].Int J Biol Sci,2020,16(12):2029-2041. [14] Kamerkar S,LeBleu V S,Sugimoto H,et al.Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer[J].Nature,2017,546(7659):498-503. [15] Bai J,Duan J,Liu R,et al.Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells[J].Asian J Pharm Sci,2020,15(4):461-471. [16] Mani S A,Guo W,Liao M J,et al.The epithelial-mesenchymal transition generates cells with properties of stem cells[J].Cell,2008,133(4):704-715. [17] Aqil F,Munagala R,Jeyabalan J,et al.Milk exosomes-natural nanoparticles for siRNA delivery[J].Cancer Lett,2019,449:186-195. [18] 王艳,张宇卉,胡耐博,等.原发性骨髓纤维化向AML转化过程中造血干细胞差异表达基因的生物学功能分析及核心基因筛选[J].山东医药,2021,61(33):6-10. Wang Y,Zhang Y H,Hu N B,et al.Bioinformatic analysis of differentially expressed genes and screening of core genes in hematopoietic stem cells during transformation from primary myelofibrosis to AML[J].Shandong Med J,2021,61(33):6-10. [19] 连玲艳.LncRNA ANCR通过上调HNRNPA1表达促进肝细胞癌转移的机制研究[D].南昌:南昌大学医学部,2020. Lian L Y.Mechanism of lncRNA ANCR promoting hepatocellular carcinoma metastasis by upregulating HNRNPA1 expression[D].Nanchang:Medical College of Nanchang University,2020. [20] Shikauchi Y,Saiura A,Kubo T,et al.SALL3 interacts with DNMT3A and shows the ability to inhibit CpG island methylation in hepatocellular carcinoma[J].Mol Cell Biol,2009,29(7):1944-1958. [21] Srichan B,Prathaphan S,Thongsri N,et al.Cross-talk between energy metabolism and epigenetics during temperature stress response in C2C12 myoblasts[J].Int J Hyperthermia,2019,36(1):776-784. [22] Tian Y,Li S,Song J,et al.A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy[J].Biomaterials,2014,35(7):2383-2390. [23] El-Andaloussi S,Lee Y,Lakhal S,et al.Exosome-mediated delivery of siRNA in vitro and in vivo[J].Nat Protoc,2012,7(12):2112-2126. [24] Wang H Y,Wang X H,Zhang Y,et al.Systemic delivery of NAC-1 siRNA by neuropilin-targeted polymersomes sensitizes antiangiogenic therapy of metastatic triple-negative breast cancer[J].Biomacromolecules,2020,21(12):103-109. [25] Zhang B,Zhang Y J,Zhang X P,et al.The CCCTC-binding factor(CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma[J].J Pathol,2017,243(4):418-430. [26] Wei L,Liu Q,Huang Y,et al.Knockdown of CTCF reduces the binding of EZH2 and affects the methylation of the SOCS3 promoter in hepatocellular carcinoma[J].Int J Biochem Cell Biol,2020,120:105685. [27] Shen H J,Li D,Wang X J,et al.HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression[J].J Hematol Oncol,2020,13(1):24. [28] Alvarez-Erviti L,Seow Y,Yin H,et al.Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes[J].Nat Biotechnol,2011,29(4):341-345. [29] Zhang B,Luo Q,Mao X F,et al.A synthetic collective intelligence platform for individualized treatment in patients with hepatocellular carcinoma[J].Hepatol Res,2020,50(5):596-609. [30] Kemp C J,Moore J M,Moser R,et al.CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancer[J].Cell Rep,2014,7(4):1020-1029. [31] Ren G,Jin W,Cui K,et al.CTCF-mediated enhancer-promoter interaction is a critical regulator of cell-to-cell variation of gene expression[J].Mol Cell,2017,67(6):1049-1058. |